Skip to Content
Merck
  • Synergistic gene editing in human iPS cells via cell cycle and DNA repair modulation.

Synergistic gene editing in human iPS cells via cell cycle and DNA repair modulation.

Nature communications (2020-06-10)
Thomas L Maurissen, Knut Woltjen
ABSTRACT

Precise gene editing aims at generating single-nucleotide modifications to correct or model human disease. However, precision editing with nucleases such as CRIPSR-Cas9 has seen limited success due to poor efficiency and limited practicality. Here, we establish a fluorescent DNA repair assay in human induced pluripotent stem (iPS) cells to visualize and quantify the frequency of DNA repair outcomes during monoallelic and biallelic targeting. We found that modulating both DNA repair and cell cycle phase via defined culture conditions and small molecules synergistically enhanced the frequency of homology-directed repair (HDR). Notably, targeting in homozygous reporter cells results in high levels of editing with a vast majority of biallelic HDR outcomes. We then leverage efficient biallelic HDR with mixed ssODN repair templates to generate heterozygous mutations. Synergistic gene editing represents an effective strategy to generate precise genetic modifications in human iPS cells.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Nocodazole, ≥99% (TLC), powder
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Mirin, ≥98% (HPLC), powder
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
RS-1, ≥98% (HPLC)
SKU
Pack Size
Availability
Price
Quantity